INTRODUCTION
Mobilized peripheral blood stem cells (PBSC) are increasingly used in allogeneic hematopoietic stem cell transplantation due to their relative ease of collection and rapid hematopoietic reconstitution. [1] [2] [3] In this setting, the donor's mobilization response to granulocyte-colony stimulating factor (G-CSF) and subsequent CD34 + apheresis yields may exert a significant effect on transplant outcomes and donation experiences. 4 A small percentage of healthy donors have a poor mobilization response to G-CSF, resulting in the need for additional apheresis collections or repeat mobilization cycles in order to collect an adequate PBSC dose for engraftment and immune reconstitution. 5 Furthermore, higher CD34 + cell doses may be associated with improved transplant outcomes in some settings, 6;7 and transplant approaches involving selective depletion or manipulation of the graft may require additional or larger volume apheresis procedures to compensate for losses incurred during cell processing. Conversely, apheresis procedures in donors with very high CD34 + mobilization responses 8 and those
producing very large PBSC yields may be associated with adverse recipient outcomes such as acute graft-versus-host disease (GVHD). 9 Therefore, a reliable estimate of a donor's CD34 + cell mobilization response to G-CSF and subsequent PBSC yield, could be of value in planning transplantation approaches.
Prior studies have yielded conflicting data regarding the effect of various donor demographic, laboratory and other factors on peak donor CD34 + mobilization responses and apheresis cell yields. [10] [11] [12] [13] In addition, the effect of donor race or ethnicity on PBSC mobilization has not been previously analyzed, and no data are available regarding the impact of perimobilization donor procedures such as the performance of unstimulated apheresis for collection of cells for donor lymphocyte infusions (DLI) and other cellular therapies. To evaluate these potential effects, we analyzed factors associated with PBSC mobilization and yield in a large, ethnically diverse population of healthy allogeneic adult donors.
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MATERIALS AND METHODS

Donors
Study subjects comprised 639 consecutive allogeneic donors who underwent PBSC collection by large volume leukapheresis (LVL) following G-CSF mobilization between January 1999 and March 2006. All subjects were healthy sibling donors at least 18 years of age, who were undergoing their first PBSC mobilization and gave informed consent according to the declaration of Helsinki and NIH Institutional Review Board-approved transplantation protocols.
According to individual protocol design, 299 of these donors also underwent an unstimulated (non-G-CSF mobilized) lymphapheresis collection by LVL prior to initiation of G-CSF to collect cells for use in post-transplantation strategies designed to enhance transplant outcomes, including donor lymphocyte infusions, 14 scheduled T-cell "add-backs", 6 ;15 Th2/Tc2 cell generation 16;17 and other ex-vivo graft manipulation therapies. At each visit, donor demographic information including age, gender, height and weight was collected. Ethnicity was selfcategorized as Caucasian, African-American, Hispanic or Asian/Pacific, and is reported throughout this study as ethnicity rather than race for consistency.
Mobilization and collection of PBSC
All donors received 5 days of G-CSF (filgrastim; Amgen, Thousand Oaks, CA) with leukapheresis initiated on the morning of day 5, at least 2 hours after the last G-CSF dose. 4 
Laboratory analyses
Complete blood counts (CBC) were measured at baseline before G-CSF administration (pre-G-CSF), before and after PBSC collection following G-CSF mobilization (post-G-CSF and postapheresis, respectively), and before and after lymphapheresis for donors who underwent LVL for collection of cells for DLI (pre-DLI and post-DLI, respectively). The CBC was assayed using an electronic cell counter, and quantification of CD34 + cells before and after PBSC collection was performed by flow cytometry as previously described.
19
Statistical analysis
Graphics and standard data analysis were performed with a spreadsheet application (Excel, Microsoft, Redmond, WA Table 2 . The remaining 51 donors received a mean administered G-CSF dose outside of these ranges (mean 9.5 ±1.7, range 6.4-13.9 µg/kg/d).
As shown in Figure 1 , donors with greater weight had significantly higher post-G-CSF
CD34
+ cell counts (1A), while donors who were older had lower CD34 + cell counts (1B). In both instances, CD34 + responses were lowest in Caucasian donors ( Figure 1A and 1B) . As shown in Figure 2A and Table 2 
Effect of prior lymphapheresis on CD34 + mobilization
In accord with individual protocol designs, 299 of the 639 donors in this study underwent an unstimulated lymphapheresis for collection of cells for subsequent DLI, prior to receiving G-CSF stimulation and PBSC collection. Comparison of pre-and post-lymphapheresis complete blood counts in these donors demonstrated that the procedure significantly lowered blood hemoglobin concentration, platelet and total white blood cell (WBC) count, and lymphocyte counts (Table   3A) . As shown in Table 3B , peripheral blood hemoglobin and platelet levels, but not absolute lymphocyte levels, remained low following subsequent G-CSF administration, both before and after PBSC collection (post-G-CSF and post-apheresis), and were significantly lower in these 
Univariate and multivariate step-wise regression analysis of factors affecting CD34 + mobilization
In univariate logistic regression analysis, the strongest association with higher post-G-CSF CD34 + cell counts was observed with total G-CSF dose administered (p<10 -17 ), followed by weight (p<10 -12 ), pre-G-CSF donor platelet count (p<10 -7 ), pre-G-CSF donor mononuclear cell count ( p<10 -6 ), prior lymphapheresis for DLI collection (p=0.0008), and G-CSF dose per kg (p=0.0006). In contrast, Caucasian ethnicity (p<10 -5 ) and female gender (p=0.0006) were associated with lower CD34 + cell counts in univariate analysis, while age (p=0.06) exhibited a trend toward association with lower CD34 + cell counts. In step-wise regression after adjustment for total G-CSF dose received, higher post-G-CSF CD34 + cell counts remained significantly associated with the pre-G-CSF platelet count (p<10 -9 ), pre-G-CSF mononuclear cell count (p<10 -6 ), and prior lymphapheresis for DLI collection (p=0.02), and were negatively associated with Caucasian ethnicity (p<10 -7 ) and age (p<0.004); after this adjustment (total amount of G-CSF received), the associations of CD34 + cell counts with gender (p=0.45), weight (p=0.598),
and G-CSF dose per kg (p=0.85) ) no longer retained significance. Interestingly, donor height, which was not significantly associated with CD34 + cell counts in univariate analysis (p=0.54), exhibited a strong negative association with this parameter (p=0.0001) after adjustment for the total amount of G-CSF received.
In the final multivariate step-wise regression, higher post-G-CSF CD34 + cell counts were positively associated with total G-CSF dose (p<10 -20 ), pre-G-CSF platelet count (p<10 -6 ), pre-G-CSF absolute mononuclear cell count (p=0.005), and prior lymphapheresis for DLI collection (p=0.007), and were negatively associated with height (p<10 -6 ), female gender (p<10 -5 ),
Caucasian ethnicity (p=0.0004), and age (p=0.003); no significant association was present with weight (p=0.3) or G-CSF dose per kg (p=0.6).
In this study, female donors overall had lower post-G-CSF CD34 + cell counts than men for the total amount of G-CSF received, responses in women were overall similar to men as illustrated in Figure 5 for Caucasian donors. Figure 4 .
Demographic and laboratory parameters in donors with a poor mobilization response
DISCUSSION
This study represents the largest published analysis of PBSC yields in allogeneic donors. It is also the only series to examine the effect of donor ethnicity on CD34 + mobilization responses.
We found that the single strongest factor affecting CD34 + apheresis yields was the total amount of G-CSF administered to the donor, and that donor age, gender, and weight had reduced impact after accounting for this parameter. Similar lab studies in humans are necessary to determine genetic loci which control progenitor mobilization response. Genetic variations could exist in putative stem cell pool size, intrinsic migration properties of hematopoietic stem cells or interaction of stem cells with stromal and endothelial cell types in the bone marrow niche. 29 We found that increasing donor age was associated with a modest negative effect on CD34 + mobilization response. A smaller study by Anderlini et al 11 similarly reported that older age is associated with poor mobilization, a finding extended to female donors by Ings et al, 30 who concluded that given a choice, larger, male donors under the age of 55 years would be preferable. In contrast, other groups have reported that age is not a significant predictive factor. 12;31 In murine studies designed to determine whether aging is associated with changes in stem cell pool size or altered progenitor cell response to cytokines, Xing et al found that aged
For personal use only. on August 16, 2017 . by guest www.bloodjournal.org From mice exhibit better mobilization responses to G-CSF, and that their hematopoietic progenitor cells were characterized by reduced adhesion to marrow stroma. 32 The effect of higher G-CSF doses on enhancement of CD34 + mobilization responses in this analysis is consistent with prior studies. One study compared G-CSF 12 µg/kg twice daily to a single 10µg/kg/day dose and found that the higher dose was associated with higher CD34 + cell yields by apheresis. 33 Other studies reported that a given dose split into twice daily subcutaneous injections may be preferable to a single daily dose.
31;34
We also studied the effect of a prior lymphapheresis on subsequent PBSC yield, an association which might have practical implications given the frequent use of this modality in current transplant approaches. Our data indicate that lymphapheresis prior to PBSC mobilization is safe and acceptable in terms of associated changes in hemoglobin levels and platelet counts. Interestingly, donors who underwent prior lymphapheresis had significantly higher CD34 + apheresis yields than donors who did not undergo this procedure. This is consistent with a study performed by Korbling et al, 35 prior to cytokine use for mobilization, in which successive, frequent leukapheresis procedures were associated with significantly increased granulocyte/macrophage progenitor cell (CFUc) yields. In another study, even a single unstimulated leukapheresis was shown to increase subsequent levels of circulating progenitor cells in peripheral blood. 36 It is notable that circulating donor platelet levels in the present study as well as in these prior reports were significantly reduced following apheresis secondary to platelet loss in the apheresis device and product. This apheresis-related thrombocytopenia might have resulted in increased thrombopoietin levels, since thrombopoietin is constitutively produced and blood levels are inversely proportional to circulating platelet levels. 37 Indeed, prior studies have shown that serum thrombopoietin levels are increased following plateletpheresis procedures for platelet donation. 38;39 In turn, increased thrombopoietin levels might lead to enhanced CD34 + responses due to expansion of the marrow progenitor pool. 40 It is also possible that the relative lymphopenia produced after lymphapheresis might
For personal use only. on August 16, 2017 . by guest www.bloodjournal.org From have resulted in a positive effect on mobilization through a process similar to homeostatic recycling and peripheral expansion which has been reported to occur for T cells in lymphopenic states. 41 In addition to these effects, the actions of intact parathyroid hormone (iPTH) in mediating stem cell homing to the marrow microenvironment may also play a role during apheresis. 42 Parathyroid hormone increases the expression of the PTH/PTHrP receptor (PTH1R) on osteoblasts and increases the number and activity of osteoblasts in stromal cell cultures.
Activation of osteoblasts alters the hematopoietic stem cell niche, resulting in stem cell expansion in vitro and in vivo and dramatically improving the survival of mice receiving bone marrow transplants. Osteoblastic cells appear to be a regulatory component of the stem cell niche in vivo. 43 Interestingly, the citrate administered during leukapheresis has been shown to induce 100 to 300% increases in iPTH immediately after apheresis, with persistent 10-20% increases in iPTH observed for up to 4 days after lymphapheresis procedures in healthy donors. 44 In the current study, donors who began PBSC mobilization within 2 days after undergoing lymphapheresis were likely to have had elevated circulating iPTH levels, which in turn may have contributed to hematopoietic stem cell growth and resulted in higher CD34 + yields. Parathyroid hormone effects might also partly explain the higher CD34 + mobilization responses seen in African-American males, as this population is known to have increased bone mass 45 and bone mineral content, 46 and at least one study has shown significant increases in serum iPTH in African-American males. 47 Further studies are indicated to confirm these observations, as iPTH levels were not measured in this study.
In this study, baseline pre-G-CSF platelet counts were strongly associated with CD34 + cell counts after mobilization in both univariate and multivariate analyses. Similar findings have been reported in an Asian population by Suzuya et al, 10 who found that higher baseline platelet counts and platelet counts during mobilization were associated with higher CD34 + apheresis yields in a population of 119 donors. We also found that the total mononuclear cell count prior to Table 3B . + cell counts after G-CSF administration were higher in donors who underwent collection of donor lymphocytes by large volume leukapheresis prior to G-CSF administration compared to those who did not undergo lymphocyte collection prior to the initiation of G-CSF administration. Data above are for those donors who underwent lymphocyte collection within 2 days of starting G-CSF. + responses than male donors when plotted against the pre-G-CSF platelet count (B) and height (C); these associations were mitigated by the fact that on average, women had higher pre-G-CSF platelet counts and lower height than men. When plotted against total G-CSF received, CD34 + responses were similar in men and women (D). 
